NO20051155L - Fremgangsmate for fremstilling av en farmasoytisk aktiv forbindelse - Google Patents
Fremgangsmate for fremstilling av en farmasoytisk aktiv forbindelseInfo
- Publication number
- NO20051155L NO20051155L NO20051155A NO20051155A NO20051155L NO 20051155 L NO20051155 L NO 20051155L NO 20051155 A NO20051155 A NO 20051155A NO 20051155 A NO20051155 A NO 20051155A NO 20051155 L NO20051155 L NO 20051155L
- Authority
- NO
- Norway
- Prior art keywords
- give
- rizatriptan
- reaction
- preparation
- hydrazone
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- HCUARRIEZVDMPT-UHFFFAOYSA-N Indole-2-carboxylic acid Chemical compound C1=CC=C2NC(C(=O)O)=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-N 0.000 abstract 4
- 150000007857 hydrazones Chemical class 0.000 abstract 3
- TXHZXHICDBAVJW-UHFFFAOYSA-N rizatriptan Chemical compound C=1[C]2C(CCN(C)C)=CN=C2C=CC=1CN1C=NC=N1 TXHZXHICDBAVJW-UHFFFAOYSA-N 0.000 abstract 3
- 229960000425 rizatriptan Drugs 0.000 abstract 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 2
- MMCPOSDMTGQNKG-UHFFFAOYSA-N anilinium chloride Chemical compound Cl.NC1=CC=CC=C1 MMCPOSDMTGQNKG-UHFFFAOYSA-N 0.000 abstract 2
- 238000006243 chemical reaction Methods 0.000 abstract 2
- 238000006460 hydrolysis reaction Methods 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- HCUARRIEZVDMPT-UHFFFAOYSA-M 1h-indole-2-carboxylate Chemical compound C1=CC=C2NC(C(=O)[O-])=CC2=C1 HCUARRIEZVDMPT-UHFFFAOYSA-M 0.000 abstract 1
- 238000006783 Fischer indole synthesis reaction Methods 0.000 abstract 1
- BIVUUOPIAYRCAP-UHFFFAOYSA-N aminoazanium;chloride Chemical compound Cl.NN BIVUUOPIAYRCAP-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000012954 diazonium Substances 0.000 abstract 1
- 150000001989 diazonium salts Chemical class 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- 230000032050 esterification Effects 0.000 abstract 1
- 238000005886 esterification reaction Methods 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- OLYUSKJHJHSMGA-UHFFFAOYSA-N oxane-2,3-dione Chemical compound O=C1CCCOC1=O OLYUSKJHJHSMGA-UHFFFAOYSA-N 0.000 abstract 1
- 230000020477 pH reduction Effects 0.000 abstract 1
- 238000007127 saponification reaction Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000005809 transesterification reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200201874A ES2204303B2 (es) | 2002-08-07 | 2002-08-07 | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
| PCT/IB2003/003540 WO2004014877A1 (en) | 2002-08-07 | 2003-08-05 | Process for preparing rizatriptan |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20051155L true NO20051155L (no) | 2005-03-03 |
Family
ID=31502894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20051155A NO20051155L (no) | 2002-08-07 | 2005-03-03 | Fremgangsmate for fremstilling av en farmasoytisk aktiv forbindelse |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7279581B2 (de) |
| EP (1) | EP1527053B8 (de) |
| KR (1) | KR20050039749A (de) |
| AT (1) | ATE312084T1 (de) |
| AU (1) | AU2003250478A1 (de) |
| DE (1) | DE60302671D1 (de) |
| ES (2) | ES2204303B2 (de) |
| IS (1) | IS7702A (de) |
| NO (1) | NO20051155L (de) |
| TW (1) | TW200404798A (de) |
| WO (1) | WO2004014877A1 (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04012923A (es) * | 2002-06-27 | 2005-03-31 | Sb Pharmco Inc | Sales de fosfato de carvedilol y/o solvatos de las mismas, composiciones correspondientes y/o metodos de tratamiento. |
| ES2204302B2 (es) * | 2002-08-07 | 2005-03-01 | Laboratorios Vita, S.A. | Procedimiento para la obtencion de un compuesto farmaceuticamente activo. |
| EP1709032A2 (de) | 2004-01-09 | 2006-10-11 | Ratiopharm GmbH | Kristalline formen von rizatriptanbenzoat |
| ATE461916T1 (de) * | 2004-01-28 | 2010-04-15 | Ratiopharm Gmbh | Syntheseverfahren und zwischenprodukte zur herstellung von rizatriptan |
| EP1951713A1 (de) * | 2005-11-14 | 2008-08-06 | Matrix Laboratories Ltd | Verfahren zur herstellung von rizatriptanbenzoat im grossmasstab |
| US20110313171A1 (en) * | 2006-01-19 | 2011-12-22 | Chandra Purna Ray | Conversion of aromatic diazonium salt to aryl hydrazine |
| CA3010568C (en) | 2016-01-27 | 2023-10-17 | Instar Technologies A.S. | Oromucosal nanofiber carriers for therapeutic treatment |
| CN115353492A (zh) * | 2022-08-26 | 2022-11-18 | 浙江野风药业股份有限公司 | 一种连续合成1-(4-肼基苯基)甲基-1,2,4-三氮唑的方法 |
| CN115417859B (zh) * | 2022-09-19 | 2024-02-02 | 陕西师范大学 | 一种苯甲酸利扎曲坦的合成方法 |
| CN116283924B (zh) * | 2023-01-16 | 2024-07-26 | 四川效佳科技有限公司 | 一种药用级纯度的苯甲酸利扎曲普坦的重结晶方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SK278998B6 (sk) * | 1991-02-01 | 1998-05-06 | Merck Sharp & Dohme Limited | Deriváty imidazolu, triazolu a tetrazolu, spôsob i |
| ES2033578B1 (es) * | 1991-06-06 | 1995-01-16 | Quimica Sint S A Con El 50 | Procedimiento para la obtencion de 3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida. |
| ES2033577B1 (es) * | 1991-06-06 | 1995-01-16 | Quimica Sint S A Con El 50 | Procedimiento para la obtencion de la 2-carboxi-3-(2-(dimetilamino)etil)-n-metil-1h-indol-5-metanosulfonamida y sus esteres alquilicos inferiores. |
| GB9215526D0 (en) * | 1992-07-22 | 1992-09-02 | Merck Sharp & Dohme | Chemical process |
| US5567824A (en) * | 1994-05-24 | 1996-10-22 | Merck & Co., Inc. | Palladium catalyzed ring closure of triazolyltryptamine |
| AU4053497A (en) | 1996-08-13 | 1998-03-06 | Merck & Co., Inc. | Palladium catalyzed indolization |
| US5998438A (en) * | 1996-11-26 | 1999-12-07 | Allelix Biopharmaceuticals, Inc. | 5-cyclo indole compounds |
| GB9926250D0 (en) * | 1999-11-06 | 2000-01-12 | Knoll Ag | Chemical process |
-
2002
- 2002-08-07 ES ES200201874A patent/ES2204303B2/es not_active Expired - Fee Related
-
2003
- 2003-08-05 AT AT03784405T patent/ATE312084T1/de not_active IP Right Cessation
- 2003-08-05 TW TW092121365A patent/TW200404798A/zh unknown
- 2003-08-05 KR KR1020047012028A patent/KR20050039749A/ko not_active Ceased
- 2003-08-05 DE DE60302671T patent/DE60302671D1/de not_active Expired - Lifetime
- 2003-08-05 WO PCT/IB2003/003540 patent/WO2004014877A1/en not_active Ceased
- 2003-08-05 EP EP03784405A patent/EP1527053B8/de not_active Expired - Lifetime
- 2003-08-05 US US10/509,918 patent/US7279581B2/en not_active Expired - Lifetime
- 2003-08-05 AU AU2003250478A patent/AU2003250478A1/en not_active Abandoned
- 2003-08-05 ES ES03784405T patent/ES2254982T3/es not_active Expired - Lifetime
-
2005
- 2005-02-21 IS IS7702A patent/IS7702A/is unknown
- 2005-03-03 NO NO20051155A patent/NO20051155L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2204303B2 (es) | 2004-12-16 |
| ATE312084T1 (de) | 2005-12-15 |
| EP1527053B8 (de) | 2006-03-08 |
| US7279581B2 (en) | 2007-10-09 |
| US20050148778A1 (en) | 2005-07-07 |
| EP1527053B1 (de) | 2005-12-07 |
| TW200404798A (en) | 2004-04-01 |
| AU2003250478A1 (en) | 2004-02-25 |
| DE60302671D1 (de) | 2006-01-12 |
| ES2204303A1 (es) | 2004-04-16 |
| EP1527053A1 (de) | 2005-05-04 |
| KR20050039749A (ko) | 2005-04-29 |
| ES2254982T3 (es) | 2006-06-16 |
| WO2004014877A1 (en) | 2004-02-19 |
| IS7702A (is) | 2005-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7202364B2 (en) | Certain phenylacetic acids and derivatives | |
| EP1527053B8 (de) | Verfahren zur herstellung von rizatriptan | |
| CY1109532T1 (el) | Παραγωγα ινδολο 1-οξεικου οξεος με pgd2 ανταγωνιστικη δραστικοτητα | |
| TW200626580A (en) | Synthesis of (5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester | |
| HRP20100054T1 (hr) | Dobivanje pregabalina i njemu sličnih spojeva | |
| NZ600767A (en) | Enzymatic process for obtaining 17 alpha-monoesters of cortexolone and/or its 9,11-dehydroderivatives | |
| MY156546A (en) | Process for the regioselective preparation of 1-alkyl-3-haloalkylpyrazole-4-carboxylic acid derivatives | |
| NO20051178L (no) | Fremgangsmate til fremstilling av zolmitriptanforbindelser | |
| NZ315040A (en) | method of preparing (S)-4-{[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl}-2-oxazolidinone | |
| CY1109114T1 (el) | Βελτιωμενη μεθοδος διεργασιων για την παρασκευη ραμιπριλης | |
| TNSN05140A1 (en) | Perindopril | |
| Janczuk et al. | Ytterbium triflate catalyzed electrophilic substitution of indoles: the synthesis of unnatural tryptophan derivatives | |
| NZ544004A (en) | Novel method for the synthesis of perindopril and the pharmaceutically acceptable salts thereof | |
| US20080214646A1 (en) | Novel Nsaids Possessing a Nitric Oxide Donor Diazen-1-Ium-1,2-Diolate Moiety | |
| Danchev et al. | Synthesis, acute toxicity, and analgesic activity of new derivatives of pyrrole | |
| MA28144A1 (fr) | Nouveau procede de synthese du perindopril et de ses sels pharmaceutiquement acceptables | |
| ES2386989T3 (es) | Derivados de ácido fenilacético como inhibidores de COX-2 | |
| WO2009074524A3 (de) | Verfahren zur enzymatischen reduktion von alpha-dehydroaminosäuren unter verwendung von enoat dehydrogenasen | |
| AR026362A1 (es) | Procedimiento quimico | |
| García-Reynaga et al. | Biomimetic synthesis of Cbz-(S)-dolaphenine | |
| ES2377890B1 (es) | Procedimiento para obtener derivados de pirazol enantioméricamente enriquecidos. | |
| DK1765770T3 (da) | Fremgangsmåde til fremstilling af gabapentin | |
| AU2002345522A1 (en) | Process for the production of lisinopril | |
| WO2004099138A3 (en) | Process for the preparation of perindopril | |
| Lüsch et al. | New access to the synthetic building block l-aspartic acid β-semialdehyde via Grignard reaction |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |